Table 5.
Comparison of pre- and post-treatment SF-36 assessment in groups 1 and 2
| Group | Pre-treatment | Post-treatment | p value | |||
|---|---|---|---|---|---|---|
| Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | |||
| Group 1 | SF36 Vitality | 55.11 ± 21.83 | 55 (5–95) | 57.44 ± 21.26 | 55 (20–95) | 0.012♈ |
| SF36 Physical Function | 60.04 ± 23.52 | 72.2 (11.1–100) | 69.59 ± 25.1 | 72.2 (11–100) | <0.001♈ | |
| SF36 Pain | 39.39 ± 23.53 | 42.5 (0–90) | 62.39 ± 26.62 | 67.5 (0–100) | <0.001 π | |
| SF36 General Health Perception | 47.89 ± 24.20 | 50 (0–100) | 48.44 ± 23.42 | 50 (0–90) | 0.498 π | |
| SF36 Physical Role Limitation | 25.22 ± 41.52 | 0 (0–100) | 45 ± 45.73 | 25 (0–100) | 0.002♈ | |
| SF36 Emotional Role Limitation | 65.92 ± 46.32 | 100 (0–100) | 75.55 ± 41.07 | 100 (0–100) | 0.018♈ | |
| SF36 Social Function | 80.56 ± 27.25 | 100 (0–100) | 85.28 ± 21.03 | 100 (37.5–100) | 0.024♈ | |
| SF36 Mental Health | 64.10 ± 18.12 | 64 (20–96) | 65.22 ± 18.5 | 68 (20–96) | 0.136♈ | |
| Group 2 | SF36 Vitality | 52.56 ± 23.64 | 50 (5–95) | 66.78 ± 20.15 | 75 (25–90) | <0.001♈ |
| SF36 Physical Function | 57.24 ± 27.65 | 61.1 (5.6–100) | 77.63 ± 20.71 | 83.3 (22.2–100) | <0.001 π | |
| SF36 Pain | 33.28 ± 21.92 | 35 (0–90) | 67.89 ± 25.28 | 77.5 (0–100) | <0.001♈ | |
| SF36 General Health Perception | 47.56 ± 26.15 | 50 (0–100) | 54.33 ± 22.85 | 55 (10–100) | <0.001 π | |
| SF36 Physical Role Limitation | 29.44 ± 41.73 | 0 (0–100) | 70 ± 42.51 | 100 (0–100) | <0.001♈ | |
| SF36 Emotional Role Limitation | 61.48 ± 48.70 | 100 (0–100) | 88.89 ± 31.78 | 100 (0–100) | <0.001♈ | |
| SF36 Social Function | 77.78 ± 30.84 | 100 (0–100) | 95.56 ± 10.37 | 100 (50–100) | <0.001♈ | |
| SF36 Mental Health | 56.53 ± 21.48 | 62 (8–96) | 68.10 ± 1610 | 72 (28–88) | <0.001♈ | |
πPaired t test
♈Wilcoxon test
Group 1 patients receiving physical therapy and exercises for treatment
Group 2 patients receiving physical therapy, balneotherapy, and exercises for treatment
SF36 Short Form-36